Not Yet RecruitingNot Applicable

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

United States50 participantsStarted 2026-03

Plain-language summary

The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria: 1. Patient treated is age ≥ 22 years at the time of procedure 2. Use of Liberant in accordance with the device labeling within 72 hours of index procedure

What they're measuring

Rate of Device related Serious Adverse Event at Index procedure

Timeframe: Index Procedure

Rate of technical success at Index procedure

Timeframe: Index procedure

Rate of Procedural Success at Index procedure

Timeframe: Index procedure

Trial details

NCT IDNCT07335341

SponsorMedtronic Endovascular

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-08

Contact for this trial

Manasa Gudipally

763-514-4000 manasa.gudipally@medtronic.com

View on ClinicalTrials.gov More Venous Embolism of Lower Extremities (Diagnosis) trials